Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in bacterial conjugate vaccines

D Goldblatt1

  • 1Immunobiology Unit, Institute of Child Health and Great Ormond Street Hospital for Children, London.

Journal of Medical Microbiology
|December 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into the heterogeneity of pneumococcal polysaccharide vaccine immunogenicity in older adults.

Immunity & ageing : I & A·2026
Same author

Safety and Immunogenicity of a Klebsiella pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A First-in-Human Phase I/II Randomized and Controlled Study.

The Journal of infectious diseases·2025
Same author

Pneumococcal conjugate vaccine dose-ranging studies in humans: A systematic review.

Vaccine·2021
Same author

Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.

The Journal of hospital infection·2021
Same author

Interlaboratory Comparison of the Pneumococcal Multiplex Opsonophagocytic Assays and Their Level of Agreement for Determination of Antibody Function in Pediatric Sera.

mSphere·2018
Same author

Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp.

Clinical and vaccine immunology : CVI·2017
Same journal

Suggestive associations between genetically predicted gut microbiota and endometriosis: a two-sample Mendelian randomization study.

Journal of medical microbiology·2026
Same journal

Whole-genome sequencing of <i>Listeria monocytogenes</i> from maternal and neonatal clinical isolates in Kuwait.

Journal of medical microbiology·2026
Same journal

The Dynamiker cryptococcal antigen lateral flow assay is an accurate, rapid and cost effective test comparable to culture for detection of cryptococcal meningitis.

Journal of medical microbiology·2026
Same journal

R pyocin sensitivity of <i>Pseudomonas aeruginosa</i> clinical isolates from different disease types.

Journal of medical microbiology·2026
Same journal

Investigation of the efficacy of high-dose flucloxacillin therapy for borderline oxacillin-resistant (BORSA) <i>Staphylococcus aureus</i> infections of <i>Galleria mellonella</i> larvae.

Journal of medical microbiology·2026
Same journal

Corrigendum: Cases of high consequence infectious diseases identified in the UK, 1962-2023.

Journal of medical microbiology·2026
See all related articles

Conjugate vaccines link carbohydrates to proteins, making them effective against bacterial infections in young children. This technology has significantly reduced Haemophilus influenzae type b disease and is being explored for other pathogens.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Invasive bacterial infections disproportionately affect children under 4.
  • Key pathogens like Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae cause severe childhood meningitis.
  • Infants' and young children's inability to produce antibodies against bacterial capsule carbohydrates limits traditional vaccine efficacy.

Purpose of the Study:

  • To explain the immunological properties of carbohydrate antigens.
  • To highlight the limitations of pure carbohydrate vaccines in vulnerable populations.
  • To introduce conjugate vaccine technology as a solution for improving immunogenicity in young children.

Main Methods:

  • Review of immunological properties of carbohydrate antigens (T-independent response).

Related Experiment Videos

  • Explanation of conjugate vaccine technology (carbohydrate antigen coupled to a protein carrier).
  • Analysis of the impact of conjugate vaccines on invasive bacterial infections.

    • Main Results:

    • Conjugate vaccine technology overcomes the poor immunogenicity of carbohydrates in infants.
    • Haemophilus influenzae type b (Hib) conjugate vaccines have dramatically reduced invasive Hib disease incidence.
    • The success of Hib conjugate vaccines validates the approach for other bacterial pathogens.

    Conclusions:

    • Conjugate vaccines are crucial for protecting young children from invasive bacterial infections.
    • The technology is being applied to develop vaccines against Neisseria meningitidis and Streptococcus pneumoniae.
    • Developing a broadly effective pneumococcal conjugate vaccine presents significant challenges due to serotype diversity.